Laine Mello, director of Marketing at Ecolab for its bioprocessing business, shares her insights on the digital ...

Tariffs and significant US manufacturing investments complicate ROI calculations and increase operational costs, challenging ...

For much of the past decade, drug shortages in the United States were treated as episodic disruptions. In 2024, that framing ...

SK Capital Partners have signed a definitive agreement to divest the Noramco API related assets in a sale to Siegfried (Zofingen Switzerland) -- The transaction is subject to customary closing ...

SAN DIEGO, CA - January 27, 2026 (NEWMEDIAWIRE) - Quantumzyme Corp. (OTC: QTZM), a biotransformation company focused on sustainable pharmaceutical manufacturing, today announced a breakthrough ...

While the threat of U.S. import tariffs prompted a surge in drug production last year, that output is slated to slow across multiple geographies in 2026. | While the threat of U.S. import tariffs ...

PMMI research identifies top manufacturing hurdles including regulatory compliance, automation needs, and sustainability priorities ...

Recipharm, a global CDMO, has developed a new, dedicated manufacturing facility in support of the latest FDA regulatory ...

PMMI research shows pharmaceutical manufacturers face a growing market and will need OEMs and suppliers to overcome ...

Regulatory authorities in China have cracked down on Sun Pharma’s rivastigmine-based Alzheimer’s disease treatment, halting ...

In today’s Pharmaceutical Executive Daily, tariff uncertainty triggers a short-term surge in pharmaceutical manufacturing ...

Pharma and advanced therapy manufacturing will only grow more complex in science, regulation, and global scale. But the ...